PRESS RELEASESOcular Therapeutix Announces Second Medicare Administrative Contractor To Establish New Published Physician Fee Schedule For Administration Of Intracanalicular InsertsBy Business WireJul 23, 2020 7:00 AM EDT
PRESS RELEASESOcular Therapeutix Presents At The 12th Annual Ophthalmology Innovation Summit (OIS)By Business WireJul 17, 2020 7:30 AM EDT
PRESS RELEASESOcular Therapeutix™ To Present Data At The Association For Research In Vision And Ophthalmology (ARVO) Annual MeetingBy Business WireJun 15, 2020 8:00 AM EDT
PRESS RELEASESOcular Therapeutix™ To Present At The 2020 Raymond James Human Health Innovation ConferenceBy Business WireJun 10, 2020 8:00 AM EDT
PRESS RELEASESOcular Therapeutix™ To Present At The Jefferies Virtual Healthcare ConferenceBy Business WireMay 29, 2020 8:00 AM EDT
PRESS RELEASESOcular Therapeutix™ Announces Pricing Of Public Offering Of Common StockBy Business WireMay 20, 2020 7:30 AM EDT
PRESS RELEASESOcular Therapeutix™ Announces Proposed Public Offering Of Common StockBy Business WireMay 19, 2020 4:44 PM EDT
PRESS RELEASESOcular Therapeutix™ Announces First Patient Dosed In Phase 1 Clinical Trial Of OTX-CSI For The Treatment Of Dry Eye DiseaseBy Business WireMay 12, 2020 7:00 AM EDT
PRESS RELEASESOcular Therapeutix™ To Present New Data At The American Society Of Cataract And Refractive Surgery (ASCRS) 2020 Virtual Annual MeetingBy Business WireMay 11, 2020 7:00 AM EDT
PRESS RELEASESOcular Therapeutix™ To Report First Quarter 2020 Financial ResultsBy Business WireApr 30, 2020 8:00 AM EDT
PRESS RELEASESOcular Therapeutix™ To Report Fourth Quarter And Year-End 2019 Financial ResultsBy Business WireMar 5, 2020 8:00 AM EST
PRESS RELEASESOcular Therapeutix™ Announces Preliminary Fourth Quarter 2019 Net Product Revenue And Provides Update On Interim Data From The OTX-TKI Phase 1 Clinical Trial At The Cowen 40th Annual Health Care ConferenceBy Business WireMar 3, 2020 7:30 AM EST
PRESS RELEASESOcular Therapeutix™ To Present At The Cowen And Company 40th Annual Health Care ConferenceBy Business WireFeb 25, 2020 8:00 AM EST
PRESS RELEASESOcular Therapeutix™ Presents Data Demonstrating A Clinically-Meaningful Reduction In Intraocular Pressure In Patients With Primary Open Angle Glaucoma Or Ocular Hypertension Treated With OTX-TIC At Glaucoma 360 ConferenceBy Business WireFeb 7, 2020 8:00 AM EST
MARKETSOcular therapeutix (ocul) stock soars on regeneron dealBy Annie PalmerOct 13, 2016 12:05 PM EDT
MARKETSToday's Weak On High Volume Stock: Ocular Therapeutix (OCUL)By TheStreet WireAug 9, 2016 10:00 AM EDT
MARKETSOcular therapeutix (ocl) stock soars, fda: corrective actions address concernsBy Rachel AldrichAug 4, 2016 12:38 PM EDT
MARKETSOcular Therapeutix (OCUL) Stock: Weak On High Volume TodayBy TheStreet WireJul 12, 2016 10:00 AM EDT
MARKETSStocks hover near session highs ahead of Yellen speechBy Keris Alison LahiffJun 6, 2016 11:22 AM EDT
MARKETSStock futures inch higher as Wall Street awaits YellenBy Keris Alison LahiffJun 6, 2016 7:44 AM EDT
